t.nguyen_new

TL1 Member · Brisbane, AU

Two months in. Mostly questions, slowly fewer of them.

Joined 28 July 2025 · last posted 4d

21Posts here

2Topics

1Solutions

173Likes received

74Likes given

16Badges

79Days visited

409Posts read

Stated areas

learning

Recent activity

Full stream

What I would want from a home test that does not exist yet — what changed since Replied, post #107 · Analytics › Home & field testing · 24 Jul 2026 · 0 likes Worth separating two things that post #103 runs together. Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #112 · Outcomes › Body composition · 10 Jul 2026 · 22 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
A site rotation scheme that is easy enough to actually follow Replied, post #103 · Practice › Administration · 1 Jul 2026 · 10 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #55 · Sourcing › Independent verification · 1 Jul 2026 · 6 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
Primary endpoint hierarchies and why order matters — one year on Replied, post #21 · Evidence › Trials · 21 Jun 2026 · 9 likes post #20 answers the question as asked. The question underneath it is different. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #72 · Data & Tools › Datasets · 29 May 2026 · 1 like Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #21 · Analytics › Method validation · 14 May 2026 · 18 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
Interim analyses and stopping rules Replied, post #17 · Evidence › Trials · 24 Mar 2026 · 8 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
Citing a preprint in a maintained document: our rule and its reasoning Replied, post #3 · Evidence › Preprints · 15 Mar 2026 · 0 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #4 · Compounds › Repair & healing peptides · 7 Mar 2026 · 0 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #114 · Access › International · 17 Feb 2026 · 7 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
Why chargeback is not the safety net people assume Started this topic · Sourcing › Payments · 7 Feb 2026 · 43 likes Asking directly, because I could not find a straight answer: Why chargeback is not the safety net people assume A logistics question, since the answers here are usually…